Financial Management Professionals’s Recursion Pharmaceuticals RXRX Stock Holding History

Financial Management Professionals’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.17K	Hold	1,410	–	–	﹤0.01%	682
2026 Q1	$4.33K	Hold	1,410	–	–	﹤0.01%	639
2025 Q4	$5.77K	Hold	1,410	–	–	﹤0.01%	604
2025 Q3	$6.88K	Hold	1,410	–	–	﹤0.01%	566
2025 Q2	$7.13K	Buy	+1,410	New	+$6.93K	﹤0.01%	590
2025 Q1	–	Sell	-840	Closed	-$5.68K	–	1038
2024 Q4	$5.68K	Hold	840	–	–	﹤0.01%	596
2024 Q3	$6K	Hold	840	–	–	﹤0.01%	618
2024 Q2	$6K	Hold	840	–	–	﹤0.01%	575
2024 Q1	$8K	Buy	+840	New	+$9.35K	﹤0.01%	582

Other funds holding RXRX

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AWM

Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return

NWMG

National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Financial Management Professionals's RXRX Position: Q2 2026 in Review

Financial Management Professionals held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 1,410 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Financial Management Professionals first reported a position in RXRX in Q1 2024 and has held it in 9 quarters since. The position peaked at $8K in Q1 2024. 28 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

Financial Management Professionals held 1,410 shares of Recursion Pharmaceuticals worth $5.17K as of Q2 2026.
Financial Management Professionals left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
Recursion Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #682 holding.
Financial Management Professionals first reported a position in Recursion Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Financial Management Professionals's Recursion Pharmaceuticals position peaked at $8K in Q1 2024.
28 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.